Peri-operative plasma disappearance rate of indocyanine green after coronary artery bypass surgery

Cardiovascular Journal of Africa

Volumn 18, Issue 6, 2007, Pages 375-379

  Sander, Michael ^a   Spies, Claudia D ^a   Foer, Achim ^a   Syn, Doh Yung ^a   Grubitzsch, Herko ^a   Von Heymann, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DATA ANALYSIS; ELECTIVE SURGERY; ETHICS; FEMALE; HEART INDEX; HUMAN; INFORMED CONSENT; INTENSIVE CARE UNIT; MALE; PERIOPERATIVE PERIOD; PLASMA; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY;

AGED; COLORING AGENTS; CORONARY ARTERY BYPASS; HUMANS; INDOCYANINE GREEN; LIVER CIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; SPLANCHNIC CIRCULATION; SURGICAL PROCEDURES, ELECTIVE;

EID: 39749165728     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Grover FL. The Society of Thoracic Surgeons National Database: current status and future directions. Ann Thorac Surg 1999; 68(2): 367-373.
2. Bach F, Silomon M, Grundmann U, Sturner J, Graeter T, Larsen R. [Effects of dopexamine on splanchnic perfusion in cardiac surgery]. Anaesthesist 1999; 48(10): 713-717.
3. Ohri SK, Bjarnason I, Pathi V, Somasundaram S, Bowles CT, Keogh BE, Khaghani A, Menzies I, Yacoub MH, Taylor KM. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg 1993; 55(5): 1080-1086.
4. Ott MJ, Buchman TG, Baumgartner WA. Postoperative abdominal complications in cardiopulmonary bypass patients: a case-controlled study. Ann Thorac Surg 1995; 59(5): 1210-1213.
5. Dantzker DR. The gastrointestinal tract. The canary of the body? J Am Med Assoc 1993; 270(10): 1247-1248.
6. Meier-Hellmann A, Reinhart K, Bredle DL, Sakka SG. Therapeutic options for the treatment of impaired gut function. J Am Soc Nephrol 2001; 12(Suppl 17): S65-S69.
7. Tamion F, Richard V, Sauger F, Menard JF, Girault C, Richard JC, Thuillez C, Leroy J, Bonmarchand G. Gastric mucosal acidosis and cytokine release in patients with septic shock. Crit Care Med 2003; 31(8): 2137-2143.
8. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 2002; 17(6): 451-458.
9. Fink MP. Adequacy of gut oxygenation in endotoxemia and sepsis. Crit Care Med 1993; 21(2 Suppl): S4-S8.
10. Siems W, Kowalewski J, Werner A, Schimke I, Gerber G. Radical formation in the rat small intestine during and following ischemia. Free Radic Res Commun 1989; 7(3-6): 347-353.
11. Valentine BA, Blue JT, Shelley SM, Cooper BJ. Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog. J Vet Intern Med 1990; 4(3): 140-143.
12. Kumle B, Boldt J, Suttner SW, Piper SN, Lehmann A, Blome M. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 2003; 75(5): 1558-1564.
13. Kern H, Schroder T, Kaulfuss M, Martin M, Kox WJ, Spies CD. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001; 29(8): 1519-1525.
14. Lehmann C, Taymoorian K, Wauer H, Krausen D, Birnbaum J, Kox WJ. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Inten Care Med 2000; 26(10): 1557-1560.
15. Braun JP, Schroeder T, Buehner S, Dohmen P, Moshirzadeh M, Grosse J, Streit F, Schlaefke A, Armstrong VW, Oellerich M, Lochs H, Konertz W, Kox WJ, Spies C. Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand 2004; 48(6): 697-703.
16. Birnbaum J, Lehmann C, Taymoorian K, Krausch D, Wauer H, Grundling M, et al. [The effect of dopexamine and iloprost on plasma disappearance rate of indocyanine green in patients in septic shock]. Anaesthesist 2003; 52(11): 1014-1019.
17. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001; 29(6): 1159-1163.
18. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002; 122(5): 1715-1720.
19. Calafiore AM, Teodori G, Mezzetti A, Bosco G, Verna AM, Di Giammarco G, et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59(2): 398-402.
20. Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004; 10(8): 1060-1064.
21. Cherry G, Sharpe DA, Nandi J, Butler SJ, Mitchell IM. Liver blood flow during cardiac surgery. Perfusion 2004; 19(3): 153-156.
22. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97(1): 215-252.
23. Sakka SG, Reinhart K, Meier-Hellmann A. Does the optimization of cardiac output by fluid loading increase splanchnic blood flow? Br J Anaesth 2001; 86(5): 657-662.
24. Jakob SM, Ruokonen E, Takala J. Assessment of the adequacy of systemic and regional perfusion after cardiac surgery. Br J Anaesth 2000; 84(5): 571-577.
25. Bach F, Silomon M, Grundmann U, Sturner J, Graeter T, Larsen R. Splanchnikusperfusion unter Dopexamin bei kardiochirurgischen Eingriffen. Anaesthesist 1999; 48(10): 713-717.
26. Niemann CU, Yost CS, Mandell S, Henthorn TK. Evaluation of the splanchnic circulation with indocyanine green pharmacokinetics in liver transplant patients. Liver Transpl 2002; 8(5): 476-481.
27. Autschbach R, Falk V, Lange H, Oellerich M, Walther T, Mohr FW, Dalichau H. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass. Thorac Cardiovasc Surg 1996; 44(2): 76-80.
28. Toraman F, Evrenkaya S, Yuce M, Aksoy N, Karabulut H, Bozkulak Y, Alhan C. Lactic acidosis after cardiac surgery is associated with adverse outcome. Heart Surg Forum 2004; 7(2): E155-E159.
29. Tao W, Zwischenberger JB, Nguyen TT, Vertrees RA, McDaniel LB, Nutt LK, et al. Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 1995; 110(3): 819-828.
30. Landow L. Splanchnic lactate production in cardiac surgery patients. Crit Care Med 1993; 21(2 Suppl): S84-S91.
31. Thoren A, Jakob SM, Pradl R, Elam M, Ricksten SE, Takala J. Jejunal and gastric mucosal perfusion versus splanchnic blood flow and metabolism: an observational study on postcardiac surgical patients. Crit Care Med 2000; 28(11): 3649-3654.
32. McSweeney ME, Garwood S, Levin J, Marino MR, Wang SX, Kardatzke D, et al. Adverse gastrointestinal complications after cardiopulmonary bypass: can outcome be predicted from preoperative risk factors? AnesthAnalg 2004; 98(6): 1610-1617, table.
33. Braun JP, Schroeder T, Buehner S, Jain U, Dopfmer U, Schuster J, et al. Small-dose epoprostenol decreases systemic oxygen consumption and splanchnic oxygen extraction during normothermic cardiopulmonary bypass. Anesth Analg 2006; 102(1): 17-24.
34. Badawy AAB, Rommelspacher H, Morgan CJ, Bradley DM, Bonner A, Ehlert A, et al. Tryptophan metabolism in alcoholism, tryptophan but not excitatory amino acid availability to the brain is increased before the appearance of the alcohol-withdrawal syndrome in men. Alcohol Alcoholism 1998; 33(6): 616-625.